Cimetidine: An inhibitor or promoter of tumor growth? [1]

International Journal of Cancer

Volumn 81, Issue 5, 1999, Pages 835-838

  Sasson, A R ^a   Gamagami, R ^a   An, Z ^a   Wang, X ^a   Moossa, A R ^a   Hoffman, R M ^a  

^a ANTICANCER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; FLUOROURACIL; HISTAMINE H2 RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER INHIBITION; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; MALE; MOUSE; NONHUMAN; NUDE MOUSE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TUMOR PROMOTION; TUMOR VOLUME; TUMOR XENOGRAFT;

ADENOCARCINOMA; ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL DIVISION; CIMETIDINE; COLONIC NEOPLASMS; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RANDOM ALLOCATION; TIME FACTORS;

EID: 0032951541     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990531)81:5<835::AID-IJC27>3.0.CO;2-1     Document Type: Letter

References (20)